Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Erythropoietin Stories

2010-11-23 07:00:00

EXTON, Pa., Nov. 23, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. released ChartTrends®: Renal Anemia in Chronic Kidney Disease Non-Dialysis (CKD-ND), an annual syndicated publication based on patient and laboratory data collected from over 1,000 US CKD-ND patient charts. ChartTrends® compare what physicians self-report about disease management to what actually occurs at the patient level. This report evaluates the management of renal anemia...

2010-11-16 12:56:00

Researchers find erythropoiesis-stimulating drugs cut response to HER2 targeted therapy Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell. "Our research indicates when the two drugs were used at the same time, Herceptin was less effective," said study senior...

2010-11-16 06:00:00

CARLSBAD, Calif. and VANCOUVER, Canada, Nov. 16, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Xenon Pharmaceuticals Inc. announced today a new collaboration to discover and develop antisense drugs as novel treatments for the common disease anemia of inflammation (AI). Under the terms of the agreement, Isis will receive an undisclosed upfront payment in the form of a convertible promissory note from Xenon to discover and develop antisense drugs to the...

2010-11-10 17:30:49

Scientists are reporting development of a long-sought method with the potential for getting medication through a biological barrier that surrounds the brain, where it may limit the brain damage caused by stroke. Their approach for sneaking the nerve-protective drug erythropoietin into the brain is medicine's version of the Trojan Horse ploy straight out of ancient Greek legend. It also could help people with traumatic head injuries, Parkinson's disease, and other chronic brain disorders....

2010-11-04 12:30:00

BURLINGTON, Mass., Nov. 4, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that biosimilar erosion of branded erythropoietin stimulating agent (ESA) market share is likely to be more rapid and more complete in the United States compared to biosimilar erosion seen in Europe since biosimilar ESAs entered the European market in 2007. According to Biosimilars Advisory Service: Physician...

2010-11-01 06:00:00

DALLAS, November 1, 2010 /PRNewswire/ -- Sandler Research announces it will carry Anemia - Pipeline Assessment and Market Forecasts to 2017 Research Report in its store. Browse the complete Report on: http://www.sandlerresearch.org/reports/37162-anemia-pipeline-assessment-and-m arket-forecasts-to-2017.html Browse All Food and Beverages Reports: http://www.sandlerresearch.org/market-research/pharmaceuticals/ Search More Then 20000 Market Research Reports at...

2010-10-27 07:00:00

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrends® publications (TreatmentTrends®: US Nephrology Q310 and TreatmentTrends®: Renal Dietitians 2010). These reports provide information gleaned from on-line surveys with 200 nephrologists and 205 renal dietitians and capture insight into attitudes, perceptions and self-reported prescribing behavior with a focus on renal...

2010-10-26 11:12:50

(Ivanhoe Newswire) -- As if high blood pressure, chronic diseases, and cancer weren't enough, high levels of erythropoietin in people over 85 join the list of silent killers. Erythropoietin is a hormone created in the kidneys to stimulate production of red blood cells. Production is triggered by impaired oxygen delivery to the kidney because of anemia or low blood oxygen levels. Studies involving patients with chronic heart failure have shown that high erythropoietin levels predict poor...

2010-10-25 16:19:37

High erythropoietin levels in people over age 85 indicate a higher risk of death, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100347.pdf. Erythropoietin is a hormone created in the kidneys to stimulate production of red blood cells. Production is triggered by impaired oxygen delivery to the kidney because of anemia or low blood oxygen levels. In patients with chronic heart failure, high erythropoietin...

2010-10-18 07:03:00

THOUSAND OAKS, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC). "This advisory committee...